INSIGHTS ON CLINICAL TRIAL DESIGN
-
DCTs And Community-Based Research Execution And Compliance
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
The Path Forward In Oncology Trials
A comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.
-
Trends In Clinical Trials In 2025: Navigating A Transformative Landscape
In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.
-
Precision Medicine In Pediatrics: Biomarkers and Assay Development
Discover the rise in FDA-approved pediatric therapies and the role of precision medicine in tailoring treatments to genetic profiles, as well as how biomarkers and assays can enhance pediatric care.
-
FDA Draft Guidance On Diversity Action Plan Requirements10/24/2024
Explore new drafted guidance under FDORA that substantiates the mandate of a Diversity Action Plan (DAP) for late-stage trial protocol submissions.
-
Reducing The Burden Of Patient Retention And Improving Continuity1/6/2026
Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.
-
Clinical Trial Budgeting Faces Pressure To Modernize6/26/2026
Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.
-
Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical Trials8/20/2026
Discover how leading teams are using trusted data and targeted AI to design, plan, and execute clinical trials with the confidence today's science requires.
-
4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials5/9/2025
Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
Scout delivers patient engagement solutions that keep participants involved in clinical trials while supporting sites, sponsors, and CROs.
With tools that manage payments, travel, and communication, we make it easy for participants to stay connected and confident throughout their trial journey.
-
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.